WebDec 13, 2024 · The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive urinary symptoms … WebApr 10, 2024 · When compared with current endoscopic standard of care Optilume resulted in an estimated cost saving of £2502 per patient if introduced in the NHS for the …
Initial patient experiences of Optilume drug-coated balloon ... - ICS
WebJan 5, 2024 · Five experts agreed that Optilume has the potential to replace current standard care. One said that it will be an additional treatment for short, recurrent strictures. Three experts noted it has the potential to replace urethroplasty for short strictures, and 2 said it could replace urethrotomy. WebIntroduction: Mechanical balloon dilation and direct visualization internal urethrotomy (DVIU) are the most widely used treatments for urethral stricture disease in the U.S., but recurrence rates are high, especially after re-treatment. This study investigates the safety and efficacy of the Optilume™ paclitaxel-coated balloon for the treatment of recurrent strictures. someone who does estate sales
FDA Approves Optilume® Urethral Drug Coated Balloon, a …
WebDec 22, 2024 · Stricture sites vary from proximal, intrasphincteric, distal or at the meatus. Stricture formation after previous urethral surgery may pose a special challenge. We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the patient remains ... WebThe Optilume® Urethral Drug Coated Balloon is used to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males for urethral strictures of ≤3 cm in length. We are pleased to inform you that the PMA is approved. You may WebA Breakthrough Treatment for Urethral Stricture Disease For patients who have failed prior endoscopic management, today there is Optilume® — a breakthrough urethral drug-coated balloon treatment that dilates the urethral lumen and delivers paclitaxel directly to the stricture, significantly reducing the incidence of stricture recurrence.² small cafe organizational chart